[Press release – not published yet] Pfizer’s Covid pill remains 89% effective for reducing the risk of hospitalization or death in final analysis.
15 Dec, 2021 | 08:46h | UTCCommentaries:
Pfizer’s Covid pill remains 89% effective in final analysis, company says – STAT
Pfizer confirms COVID pill’s results, potency versus omicron – Associated Press
Related:
8 lingering questions about the new Covid pills from Merck and Pfizer.
Commentary on Twitter (thread – click for more)
@pfizer releases more nirmatrelvir (#Paxlovid) data on #COVID19 final outcomes. Data are consistent, slightly better thant interim analysis. #IDTwitter
▪️ 88% overall hospitalization <=5days
▪️ No deaths in High Risk Trial (EPIC-HR)
▪️ Stopping drug 2.1%https://t.co/1D2LKan7tM— David Boulware, MD MPH (@boulware_dr) December 14, 2021